Apollo Endosurgery, a medical technology company focused on less invasive therapies for the treatment of obesity as well as other gastrointestinal conditions, has started first commercial shipment of its OverStitch Sx endoscopic suturing system.
These initial customer shipments launch the first phase of the global product launch for Overstitch Sx.
This first phase will be a limited launch with select gastroenterologists and bariatric surgeons in both the United States and European Union through the end of this year. The full commercial launch is planned in the 1st quarter of next year.
Flexible endoscopic suturing using Apollo’s OverStitch Endoscopic Suturing System is now established as an important tool for both surgeons and gastroenterologists that enables a wide array of new endolumenally performed patient treatment options. The OverStitch Sx is designed for compatibility with single-channel endoscopes with diameters ranging from 8.8mm to 9.8mm, and therefore provides more physicians with access to the benefits of full-thickness flexible endoscopic suturing regardless of their hospital’s selection of endoscopic capital equipment or endoscope manufacturer.
Apollo Endosurgery chief medical officer Christopher Gostout said: “OverStitch Sx builds on the clinical success of OverStitch and adds features that will enhance and simplify the user’s experience. The product is designed to achieve full thickness tissue purchases easier and more consistently, increase the physician’s field of vision, and improve maneuverability when compared to the current OverStitch which operates on a dual channel scope.
“By incorporating all required ancillary channels for device operation in the product, the endoscope channel is left open for use of additional instrumentation. This feature allows physicians the opportunity to be more efficient and versatile in their procedures.”
Source: Company Press Release